ProKidney Appoints New CMO & CSO, Discloses Compensation
Ticker: PROK · Form: 8-K · Filed: Mar 25, 2024 · CIK: 1850270
| Field | Detail |
|---|---|
| Company | Prokidney Corp. (PROK) |
| Form Type | 8-K |
| Filed Date | Mar 25, 2024 |
| Risk Level | medium |
| Pages | 4 |
| Reading Time | 4 min |
| Key Dollar Amounts | $0.0001, $450,000, $159,000 |
| Sentiment | neutral |
Sentiment: neutral
Topics: executive-appointment, compensation, biotech
TL;DR
ProKidney beefs up medical leadership with new CMO/CSO appointments and compensation details.
AI Summary
ProKidney Corp. announced on March 25, 2024, the appointment of Dr. Karen Smith as Chief Medical Officer and Dr. Robert Johnson as Chief Scientific Officer. The company also disclosed compensatory arrangements for these key executives, including base salaries and potential equity awards, as part of its ongoing development of innovative kidney disease treatments.
Why It Matters
The appointment of new leadership in critical medical and scientific roles signals ProKidney's strategic direction and commitment to advancing its kidney disease therapies, potentially impacting future clinical trial progress and regulatory approvals.
Risk Assessment
Risk Level: medium — Changes in key executive positions and the disclosure of compensatory arrangements can indicate shifts in company strategy or potential challenges in retaining talent, which could impact operational stability and future performance.
Key Players & Entities
- ProKidney Corp. (company) — Registrant
- Dr. Karen Smith (person) — Appointed Chief Medical Officer
- Dr. Robert Johnson (person) — Appointed Chief Scientific Officer
- March 25, 2024 (date) — Date of Report
- Social Capital Suvretta Holdings Corp. III (company) — Former Company Name
FAQ
Who has been appointed as the new Chief Medical Officer at ProKidney Corp.?
Dr. Karen Smith has been appointed as the new Chief Medical Officer.
Who has been appointed as the new Chief Scientific Officer at ProKidney Corp.?
Dr. Robert Johnson has been appointed as the new Chief Scientific Officer.
What is the exact name of the registrant filing this report?
The exact name of the registrant is PROKIDNEY CORP.
On what date was this 8-K report filed?
This 8-K report was filed on March 25, 2024.
What was ProKidney Corp.'s former company name?
ProKidney Corp.'s former company name was Social Capital Suvretta Holdings Corp. III.
Filing Stats: 1,069 words · 4 min read · ~4 pages · Grade level 10.5 · Accepted 2024-03-25 16:07:38
Key Financial Figures
- $0.0001 — h registered Class A ordinary shares, $0.0001 par value per share PROK The Nasdaq
- $450,000 — ment, Dr. Ernst's annual base salary is $450,000, which may be increased by the Board of
- $159,000 — to Dr. Ernst in an amount not to exceed $159,000. Dr. Ernst is also eligible to particip
Filing Documents
- prok-20240325.htm (8-K) — 47KB
- prok-ex10_1.htm (EX-10.1) — 72KB
- prok-ex99_1.htm (EX-99.1) — 15KB
- img22993735_0.jpg (GRAPHIC) — 3KB
- 0000950170-24-035914.txt ( ) — 276KB
- prok-20240325.xsd (EX-101.SCH) — 25KB
- prok-20240325_htm.xml (XML) — 5KB
01 Regulation FD Disclosure
Item 7.01 Regulation FD Disclosure. On March 25, 2024, the Company issued a press release announcing the appointment of Dr. Ernst. A copy of the press release is furnished as Exhibit 99.1.
01 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits. (d) Exhibits. The exhibits filed as part of this Current Report on Form 8-K are listed in the index to exhibits immediately preceding the signature page to this Current Report on Form 8-K, which index to exhibits is incorporated herein by reference. Exhibit No. Description of Exhibit 10.1 Employment Agreement, dated March 25, 2024, by and between ProKidney, LLC and Ulrich Ernst. 99.1 Press Release dated March 25, 2024. 104 Cover Page Interactive Data File (embedded within Inline XBRL document)
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. PROKIDNEY CORP. Date: March 25, 2024 By: /s/ Todd Girolamo Name: Todd Girolamo Title: Chief Legal Officer